Cargando…
Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones
BACKGROUND: COVID-19 pandemic spread around the world swiftly; there are several diagnostic strategies available. Health workers, especially medical residents (MR), are a high-risk population for acquiring this infection. OBJECTIVE: To estimate the seroprevalence of antibodies against SARS-CoV-2 and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Mexicano del Seguro Social
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395998/ https://www.ncbi.nlm.nih.gov/pubmed/36378067 |
_version_ | 1785083705789775872 |
---|---|
author | Velázquez-Vázquez, María Guadalupe Alberti-Minutti, Paolo Campos-Aguirre, Esmeralda Benítez-Arvizu, Gamaliel |
author_facet | Velázquez-Vázquez, María Guadalupe Alberti-Minutti, Paolo Campos-Aguirre, Esmeralda Benítez-Arvizu, Gamaliel |
author_sort | Velázquez-Vázquez, María Guadalupe |
collection | PubMed |
description | BACKGROUND: COVID-19 pandemic spread around the world swiftly; there are several diagnostic strategies available. Health workers, especially medical residents (MR), are a high-risk population for acquiring this infection. OBJECTIVE: To estimate the seroprevalence of antibodies against SARS-CoV-2 and the associated factors in MR of a third level hospital. MATERIAL AND METHODS: 330 MR from different specialties were evaluated with a questionnaire and collection of blood samples for analysis by microparticle chemiluminescent immunoassay. The prevalence of previous infection was defined by seropositivity of these antibodies. Descriptive statistics and concordance between the RT-PCR tests and the presence of anti-SARS-CoV-2 IgG were used. RESULTS: Of 330 MR, 84.5% actively participated in COVID patient care. One out of 3 reported symptoms of COVID-19; in 67.6% the possible site of infection was a hospital setting not associated with the COVID area. Out of 71 symptomatic subjects, 61.9% underwent RT-PCR against SARS-CoV-2; 20 were positive. In 15.8% of the total, the presence of anti-SARS-CoV-2 IgG antibodies was determined. Only 1 out of 3 subjects with a positive PCR had antibodies, and 11.3% of the cases, even with a positive RT-PCR test, did not develop humoral immunity. CONCLUSIONS: The seroprevalence was lower than that reported at the national level, potentially due to protection measures. The main risk factor was contact with the virus in areas of the hospital not related to COVID, making it imperative to reinforce security protocols in those spaces. |
format | Online Article Text |
id | pubmed-10395998 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Instituto Mexicano del Seguro Social |
record_format | MEDLINE/PubMed |
spelling | pubmed-103959982023-08-04 Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones Velázquez-Vázquez, María Guadalupe Alberti-Minutti, Paolo Campos-Aguirre, Esmeralda Benítez-Arvizu, Gamaliel Rev Med Inst Mex Seguro Soc Aportación Original BACKGROUND: COVID-19 pandemic spread around the world swiftly; there are several diagnostic strategies available. Health workers, especially medical residents (MR), are a high-risk population for acquiring this infection. OBJECTIVE: To estimate the seroprevalence of antibodies against SARS-CoV-2 and the associated factors in MR of a third level hospital. MATERIAL AND METHODS: 330 MR from different specialties were evaluated with a questionnaire and collection of blood samples for analysis by microparticle chemiluminescent immunoassay. The prevalence of previous infection was defined by seropositivity of these antibodies. Descriptive statistics and concordance between the RT-PCR tests and the presence of anti-SARS-CoV-2 IgG were used. RESULTS: Of 330 MR, 84.5% actively participated in COVID patient care. One out of 3 reported symptoms of COVID-19; in 67.6% the possible site of infection was a hospital setting not associated with the COVID area. Out of 71 symptomatic subjects, 61.9% underwent RT-PCR against SARS-CoV-2; 20 were positive. In 15.8% of the total, the presence of anti-SARS-CoV-2 IgG antibodies was determined. Only 1 out of 3 subjects with a positive PCR had antibodies, and 11.3% of the cases, even with a positive RT-PCR test, did not develop humoral immunity. CONCLUSIONS: The seroprevalence was lower than that reported at the national level, potentially due to protection measures. The main risk factor was contact with the virus in areas of the hospital not related to COVID, making it imperative to reinforce security protocols in those spaces. Instituto Mexicano del Seguro Social 2023 /pmc/articles/PMC10395998/ /pubmed/36378067 Text en © 2023 Revista Medica del Instituto Mexicano del Seguro Social. https://creativecommons.org/licenses/by-nc-nd/4.0/Esta obra está bajo una Licencia Creative Commons Atribución-NoComercial-SinDerivar 4.0 Internacional. |
spellingShingle | Aportación Original Velázquez-Vázquez, María Guadalupe Alberti-Minutti, Paolo Campos-Aguirre, Esmeralda Benítez-Arvizu, Gamaliel Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones |
title | Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones |
title_full | Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones |
title_fullStr | Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones |
title_full_unstemmed | Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones |
title_short | Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones |
title_sort | incompatibilidad abo en el trasplante de células progenitoras hematopoyéticas y sus complicaciones |
topic | Aportación Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395998/ https://www.ncbi.nlm.nih.gov/pubmed/36378067 |
work_keys_str_mv | AT velazquezvazquezmariaguadalupe incompatibilidadaboeneltrasplantedecelulasprogenitorashematopoyeticasysuscomplicaciones AT albertiminuttipaolo incompatibilidadaboeneltrasplantedecelulasprogenitorashematopoyeticasysuscomplicaciones AT camposaguirreesmeralda incompatibilidadaboeneltrasplantedecelulasprogenitorashematopoyeticasysuscomplicaciones AT benitezarvizugamaliel incompatibilidadaboeneltrasplantedecelulasprogenitorashematopoyeticasysuscomplicaciones |